 Todd Hankinson
Concepts (418)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Craniopharyngioma | 17 | 2023 | 70 | 6.730 |
Why?
| | Pituitary Neoplasms | 14 | 2023 | 165 | 4.700 |
Why?
| | Arnold-Chiari Malformation | 11 | 2023 | 30 | 3.390 |
Why?
| | Brain Neoplasms | 23 | 2023 | 1022 | 3.100 |
Why?
| | Neurosurgical Procedures | 13 | 2023 | 164 | 2.970 |
Why?
| | Hydrocephalus | 11 | 2023 | 81 | 2.680 |
Why?
| | Brain Stem Neoplasms | 5 | 2016 | 90 | 1.990 |
Why?
| | Magnetic Resonance Imaging | 21 | 2023 | 3174 | 1.850 |
Why?
| | Atlanto-Axial Joint | 7 | 2020 | 17 | 1.820 |
Why?
| | Joint Instability | 7 | 2020 | 172 | 1.750 |
Why?
| | Ganglioglioma | 4 | 2016 | 35 | 1.700 |
Why?
| | Decompression, Surgical | 8 | 2022 | 97 | 1.600 |
Why?
| | Spinal Injuries | 4 | 2022 | 53 | 1.570 |
Why?
| | Glioma | 5 | 2021 | 306 | 1.460 |
Why?
| | Child | 71 | 2023 | 19129 | 1.430 |
Why?
| | Ventriculoperitoneal Shunt | 8 | 2023 | 33 | 1.410 |
Why?
| | Ependymoma | 9 | 2023 | 169 | 1.340 |
Why?
| | Pons | 4 | 2016 | 31 | 1.300 |
Why?
| | Spinal Fusion | 8 | 2021 | 225 | 1.300 |
Why?
| | Sella Turcica | 2 | 2017 | 12 | 1.220 |
Why?
| | Xanthomatosis | 2 | 2017 | 11 | 1.220 |
Why?
| | Dura Mater | 3 | 2021 | 29 | 1.180 |
Why?
| | Child, Preschool | 35 | 2023 | 9491 | 1.130 |
Why?
| | Tomography, X-Ray Computed | 11 | 2022 | 2436 | 1.110 |
Why?
| | Infratentorial Neoplasms | 6 | 2023 | 50 | 1.100 |
Why?
| | Cervical Vertebrae | 7 | 2023 | 115 | 1.080 |
Why?
| | Occipital Bone | 4 | 2018 | 20 | 1.020 |
Why?
| | Cervical Atlas | 2 | 2017 | 6 | 0.990 |
Why?
| | Hematoma, Epidural, Spinal | 1 | 2023 | 2 | 0.940 |
Why?
| | Humans | 109 | 2023 | 118972 | 0.880 |
Why?
| | Neck Injuries | 1 | 2022 | 20 | 0.870 |
Why?
| | Syringomyelia | 4 | 2021 | 11 | 0.860 |
Why?
| | Neural Tube Defects | 4 | 2019 | 63 | 0.860 |
Why?
| | Image Processing, Computer-Assisted | 2 | 2020 | 709 | 0.850 |
Why?
| | Neurosurgery | 3 | 2013 | 29 | 0.820 |
Why?
| | SEER Program | 4 | 2018 | 205 | 0.810 |
Why?
| | Infant | 26 | 2023 | 8293 | 0.800 |
Why?
| | Down Syndrome | 2 | 2020 | 356 | 0.780 |
Why?
| | Postoperative Complications | 11 | 2022 | 2235 | 0.760 |
Why?
| | Transcriptome | 7 | 2023 | 756 | 0.750 |
Why?
| | Cerebrospinal Fluid Shunts | 6 | 2023 | 31 | 0.740 |
Why?
| | Diagnosis, Computer-Assisted | 1 | 2020 | 66 | 0.740 |
Why?
| | Adolescent | 37 | 2023 | 18480 | 0.730 |
Why?
| | Infant, Newborn | 13 | 2022 | 5255 | 0.730 |
Why?
| | Neuroendoscopy | 3 | 2023 | 14 | 0.650 |
Why?
| | Male | 52 | 2023 | 57801 | 0.630 |
Why?
| | Central Nervous System Neoplasms | 2 | 2019 | 128 | 0.610 |
Why?
| | Pituitary Diseases | 1 | 2017 | 23 | 0.600 |
Why?
| | Axis, Cervical Vertebra | 2 | 2022 | 9 | 0.600 |
Why?
| | Meningioma | 1 | 2018 | 82 | 0.590 |
Why?
| | Meningeal Neoplasms | 1 | 2018 | 90 | 0.580 |
Why?
| | Retrospective Studies | 26 | 2023 | 12978 | 0.570 |
Why?
| | Intracranial Hemorrhages | 2 | 2020 | 77 | 0.560 |
Why?
| | Female | 53 | 2022 | 61564 | 0.560 |
Why?
| | Skull | 1 | 2017 | 127 | 0.560 |
Why?
| | Supratentorial Neoplasms | 1 | 2015 | 20 | 0.540 |
Why?
| | Ketorolac | 1 | 2015 | 18 | 0.540 |
Why?
| | EGF Family of Proteins | 1 | 2015 | 15 | 0.530 |
Why?
| | Pediatrics | 2 | 2020 | 985 | 0.530 |
Why?
| | Treatment Outcome | 22 | 2023 | 9342 | 0.530 |
Why?
| | Receptor, EphA2 | 1 | 2015 | 19 | 0.530 |
Why?
| | Lymphocyte Specific Protein Tyrosine Kinase p56(lck) | 1 | 2015 | 21 | 0.530 |
Why?
| | ErbB Receptors | 2 | 2016 | 569 | 0.530 |
Why?
| | Receptor, ErbB-3 | 1 | 2015 | 42 | 0.520 |
Why?
| | Temporal Lobe | 1 | 2015 | 90 | 0.520 |
Why?
| | Brain Injuries, Traumatic | 2 | 2019 | 318 | 0.520 |
Why?
| | Choroid Plexus Neoplasms | 1 | 2014 | 9 | 0.510 |
Why?
| | src-Family Kinases | 1 | 2015 | 90 | 0.500 |
Why?
| | Perioperative Care | 1 | 2015 | 132 | 0.490 |
Why?
| | Neoplasm Recurrence, Local | 5 | 2020 | 900 | 0.490 |
Why?
| | Young Adult | 17 | 2021 | 10793 | 0.490 |
Why?
| | Reoperation | 5 | 2023 | 557 | 0.480 |
Why?
| | Professional Practice | 1 | 2014 | 62 | 0.470 |
Why?
| | Quality of Life | 5 | 2023 | 2366 | 0.470 |
Why?
| | Data Collection | 2 | 2014 | 658 | 0.470 |
Why?
| | Moyamoya Disease | 2 | 2014 | 15 | 0.440 |
Why?
| | Anti-Inflammatory Agents, Non-Steroidal | 1 | 2015 | 304 | 0.440 |
Why?
| | Neurology | 1 | 2014 | 94 | 0.440 |
Why?
| | Drug Delivery Systems | 1 | 2015 | 306 | 0.430 |
Why?
| | Spinal Cord Injuries | 2 | 2014 | 184 | 0.420 |
Why?
| | Urethral Diseases | 1 | 2011 | 19 | 0.420 |
Why?
| | Foreign-Body Migration | 1 | 2011 | 37 | 0.410 |
Why?
| | Genomics | 1 | 2016 | 706 | 0.410 |
Why?
| | Scoliosis | 2 | 2019 | 183 | 0.400 |
Why?
| | Atlanto-Occipital Joint | 2 | 2010 | 5 | 0.400 |
Why?
| | Brain Injuries | 1 | 2016 | 484 | 0.390 |
Why?
| | Intracranial Hypertension | 2 | 2010 | 41 | 0.390 |
Why?
| | Cranial Sutures | 1 | 2010 | 9 | 0.380 |
Why?
| | Cephalometry | 1 | 2010 | 28 | 0.380 |
Why?
| | Odontoid Process | 1 | 2010 | 8 | 0.380 |
Why?
| | Craniotomy | 2 | 2008 | 69 | 0.380 |
Why?
| | Esthetics | 1 | 2010 | 36 | 0.380 |
Why?
| | Ventriculostomy | 5 | 2023 | 19 | 0.370 |
Why?
| | Craniosynostoses | 1 | 2010 | 28 | 0.370 |
Why?
| | Societies, Medical | 1 | 2014 | 703 | 0.360 |
Why?
| | Surgeons | 1 | 2014 | 243 | 0.360 |
Why?
| | Internal Fixators | 1 | 2010 | 40 | 0.360 |
Why?
| | Urinary Bladder | 1 | 2011 | 180 | 0.360 |
Why?
| | Patient Discharge | 1 | 2016 | 796 | 0.360 |
Why?
| | Spinal Diseases | 1 | 2010 | 47 | 0.360 |
Why?
| | Brain Stem | 1 | 2010 | 104 | 0.350 |
Why?
| | Anemia, Sickle Cell | 2 | 2014 | 230 | 0.350 |
Why?
| | Cerebral Ventricles | 1 | 2009 | 48 | 0.340 |
Why?
| | Brain | 5 | 2023 | 2490 | 0.330 |
Why?
| | Glomus Tumor | 1 | 2008 | 2 | 0.330 |
Why?
| | RNA, Messenger | 2 | 2017 | 2657 | 0.330 |
Why?
| | Neuroimaging | 3 | 2020 | 256 | 0.330 |
Why?
| | Chromosomes, Human, Pair 1 | 2 | 2019 | 74 | 0.330 |
Why?
| | Surgical Wound Infection | 3 | 2022 | 251 | 0.330 |
Why?
| | Orbital Neoplasms | 1 | 2008 | 21 | 0.320 |
Why?
| | Insurance, Liability | 1 | 2008 | 6 | 0.320 |
Why?
| | Cerebral Revascularization | 1 | 2008 | 15 | 0.320 |
Why?
| | Adult | 19 | 2021 | 31512 | 0.320 |
Why?
| | B7-H1 Antigen | 2 | 2020 | 144 | 0.310 |
Why?
| | Proto-Oncogene Proteins B-raf | 3 | 2019 | 202 | 0.300 |
Why?
| | Medically Underserved Area | 1 | 2008 | 87 | 0.300 |
Why?
| | Programmed Cell Death 1 Receptor | 2 | 2020 | 197 | 0.300 |
Why?
| | Follow-Up Studies | 8 | 2019 | 4596 | 0.290 |
Why?
| | Granuloma | 2 | 2017 | 87 | 0.290 |
Why?
| | Surgical Flaps | 1 | 2008 | 118 | 0.290 |
Why?
| | Clinical Decision-Making | 2 | 2019 | 278 | 0.280 |
Why?
| | Evidence-Based Medicine | 1 | 2010 | 693 | 0.280 |
Why?
| | Prognosis | 7 | 2019 | 3443 | 0.280 |
Why?
| | Radiation Injuries | 2 | 2018 | 131 | 0.250 |
Why?
| | United States | 7 | 2020 | 12555 | 0.250 |
Why?
| | Autophagy | 2 | 2019 | 315 | 0.250 |
Why?
| | Attitude of Health Personnel | 1 | 2011 | 992 | 0.240 |
Why?
| | Brain Concussion | 2 | 2022 | 470 | 0.240 |
Why?
| | Microarray Analysis | 4 | 2017 | 124 | 0.230 |
Why?
| | Combined Modality Therapy | 3 | 2019 | 1166 | 0.220 |
Why?
| | Delayed Diagnosis | 1 | 2023 | 79 | 0.220 |
Why?
| | Germinoma | 1 | 2022 | 12 | 0.220 |
Why?
| | Pinealoma | 1 | 2022 | 11 | 0.220 |
Why?
| | Pineal Gland | 1 | 2022 | 13 | 0.220 |
Why?
| | Biomarkers, Tumor | 2 | 2019 | 1059 | 0.220 |
Why?
| | Cysts | 1 | 2023 | 93 | 0.220 |
Why?
| | Tumor Microenvironment | 3 | 2023 | 454 | 0.210 |
Why?
| | Hypothalamic Neoplasms | 1 | 2022 | 10 | 0.210 |
Why?
| | Hedgehog Proteins | 2 | 2022 | 175 | 0.210 |
Why?
| | Hypothalamic Diseases | 1 | 2022 | 18 | 0.210 |
Why?
| | Spine | 1 | 2023 | 144 | 0.200 |
Why?
| | Gene Expression Regulation, Neoplastic | 4 | 2022 | 1167 | 0.200 |
Why?
| | Endoscopy | 2 | 2015 | 272 | 0.200 |
Why?
| | Drug Screening Assays, Antitumor | 2 | 2021 | 189 | 0.200 |
Why?
| | Chromosome Aberrations | 2 | 2023 | 136 | 0.200 |
Why?
| | Radiation | 1 | 2021 | 26 | 0.200 |
Why?
| | Traction | 1 | 2021 | 19 | 0.200 |
Why?
| | Neurosurgeons | 2 | 2019 | 16 | 0.200 |
Why?
| | Cranial Fossa, Posterior | 1 | 2020 | 17 | 0.190 |
Why?
| | Kaplan-Meier Estimate | 4 | 2020 | 842 | 0.190 |
Why?
| | Middle Aged | 12 | 2020 | 27617 | 0.190 |
Why?
| | Databases, Factual | 2 | 2016 | 1231 | 0.190 |
Why?
| | Equipment Failure | 1 | 2020 | 114 | 0.190 |
Why?
| | Preoperative Period | 1 | 2020 | 110 | 0.190 |
Why?
| | Cerebellar Neoplasms | 1 | 2022 | 135 | 0.180 |
Why?
| | Sports | 1 | 2022 | 194 | 0.180 |
Why?
| | Neoplastic Cells, Circulating | 1 | 2020 | 62 | 0.180 |
Why?
| | Medulloblastoma | 1 | 2022 | 177 | 0.180 |
Why?
| | Neoplasms, Neuroepithelial | 1 | 2019 | 18 | 0.180 |
Why?
| | Prophylactic Surgical Procedures | 1 | 2019 | 6 | 0.180 |
Why?
| | Benchmarking | 1 | 2021 | 172 | 0.180 |
Why?
| | Gene Expression Profiling | 4 | 2020 | 1597 | 0.180 |
Why?
| | Spinal Cord Diseases | 1 | 2019 | 39 | 0.170 |
Why?
| | Adenomatous Polyposis Coli | 1 | 2019 | 31 | 0.170 |
Why?
| | Optic Nerve Neoplasms | 1 | 2019 | 10 | 0.170 |
Why?
| | Optic Chiasm | 1 | 2019 | 18 | 0.170 |
Why?
| | Intracranial Pressure | 1 | 2019 | 53 | 0.170 |
Why?
| | Cohort Studies | 6 | 2021 | 5116 | 0.170 |
Why?
| | Neoplasm Grading | 2 | 2021 | 258 | 0.170 |
Why?
| | Hematoma, Subdural | 1 | 2018 | 17 | 0.170 |
Why?
| | Meningomyelocele | 1 | 2019 | 51 | 0.170 |
Why?
| | Single-Cell Analysis | 1 | 2020 | 187 | 0.170 |
Why?
| | Cerebellum | 1 | 2020 | 203 | 0.170 |
Why?
| | Cell Line, Tumor | 4 | 2019 | 2851 | 0.170 |
Why?
| | Craniospinal Irradiation | 1 | 2018 | 4 | 0.160 |
Why?
| | Spinal Curvatures | 1 | 2018 | 3 | 0.160 |
Why?
| | Multivariate Analysis | 3 | 2020 | 1474 | 0.160 |
Why?
| | Decompressive Craniectomy | 1 | 2018 | 11 | 0.160 |
Why?
| | Risk Factors | 7 | 2022 | 9000 | 0.160 |
Why?
| | Chemoradiotherapy | 1 | 2019 | 200 | 0.160 |
Why?
| | Specialties, Surgical | 1 | 2019 | 76 | 0.160 |
Why?
| | Stromal Cells | 1 | 2018 | 102 | 0.160 |
Why?
| | Skull Neoplasms | 1 | 2017 | 22 | 0.160 |
Why?
| | Bone Transplantation | 1 | 2018 | 99 | 0.160 |
Why?
| | Bone Resorption | 1 | 2018 | 80 | 0.160 |
Why?
| | Cyst Fluid | 1 | 2017 | 27 | 0.160 |
Why?
| | Oncogene Proteins, Fusion | 1 | 2019 | 181 | 0.160 |
Why?
| | Hypophysitis | 1 | 2017 | 2 | 0.150 |
Why?
| | Aged | 7 | 2019 | 19657 | 0.150 |
Why?
| | Aged, 80 and over | 4 | 2018 | 6561 | 0.150 |
Why?
| | beta Catenin | 1 | 2019 | 219 | 0.150 |
Why?
| | Glioblastoma | 2 | 2010 | 262 | 0.150 |
Why?
| | Nurses | 1 | 2019 | 142 | 0.150 |
Why?
| | Re-Irradiation | 1 | 2016 | 8 | 0.150 |
Why?
| | Sarcoma, Ewing | 1 | 2017 | 65 | 0.150 |
Why?
| | Patient Admission | 1 | 2018 | 176 | 0.150 |
Why?
| | Survival Analysis | 2 | 2023 | 1267 | 0.140 |
Why?
| | Chloroquine | 1 | 2017 | 64 | 0.140 |
Why?
| | Algorithms | 2 | 2022 | 1541 | 0.140 |
Why?
| | Blood Transfusion | 1 | 2019 | 306 | 0.140 |
Why?
| | Models, Theoretical | 1 | 2020 | 556 | 0.140 |
Why?
| | Observer Variation | 1 | 2017 | 309 | 0.140 |
Why?
| | Antineoplastic Agents | 2 | 2018 | 1974 | 0.140 |
Why?
| | Age Factors | 3 | 2020 | 2995 | 0.140 |
Why?
| | Organ Size | 1 | 2017 | 460 | 0.140 |
Why?
| | MAP Kinase Signaling System | 1 | 2018 | 292 | 0.140 |
Why?
| | Delphi Technique | 3 | 2022 | 164 | 0.140 |
Why?
| | Accidents, Traffic | 2 | 2014 | 178 | 0.140 |
Why?
| | Athletic Injuries | 1 | 2022 | 495 | 0.140 |
Why?
| | Cetirizine | 1 | 2015 | 1 | 0.140 |
Why?
| | Nasal Sprays | 1 | 2015 | 2 | 0.140 |
Why?
| | Ambrosia | 1 | 2015 | 7 | 0.140 |
Why?
| | Length of Stay | 2 | 2019 | 1032 | 0.130 |
Why?
| | Amphiregulin | 1 | 2015 | 21 | 0.130 |
Why?
| | Cataract | 1 | 2018 | 194 | 0.130 |
Why?
| | Fluticasone | 1 | 2015 | 87 | 0.130 |
Why?
| | Rhinitis, Allergic, Seasonal | 1 | 2015 | 32 | 0.130 |
Why?
| | Cytokines | 3 | 2018 | 1900 | 0.130 |
Why?
| | Indoles | 1 | 2017 | 316 | 0.120 |
Why?
| | Radiography | 4 | 2023 | 861 | 0.120 |
Why?
| | Cerebral Veins | 1 | 2014 | 16 | 0.120 |
Why?
| | Logistic Models | 3 | 2019 | 1901 | 0.120 |
Why?
| | Sulfonamides | 1 | 2017 | 445 | 0.120 |
Why?
| | Disease-Free Survival | 1 | 2015 | 649 | 0.110 |
Why?
| | Arachnoid Cysts | 1 | 2013 | 7 | 0.110 |
Why?
| | Survival Rate | 2 | 2019 | 1720 | 0.110 |
Why?
| | Central Nervous System Cysts | 1 | 2013 | 12 | 0.110 |
Why?
| | Seasons | 1 | 2015 | 461 | 0.110 |
Why?
| | Carcinoma | 1 | 2014 | 204 | 0.110 |
Why?
| | Disease Models, Animal | 2 | 2019 | 3730 | 0.110 |
Why?
| | Imaging, Three-Dimensional | 3 | 2017 | 499 | 0.110 |
Why?
| | Neuroectodermal Tumors, Primitive | 1 | 2012 | 13 | 0.110 |
Why?
| | Neuropsychological Tests | 2 | 2023 | 1032 | 0.110 |
Why?
| | Anti-Bacterial Agents | 1 | 2022 | 1510 | 0.110 |
Why?
| | Cerebral Angiography | 2 | 2014 | 116 | 0.110 |
Why?
| | Emergency Service, Hospital | 1 | 2023 | 1864 | 0.110 |
Why?
| | Drug Resistance, Neoplasm | 1 | 2017 | 671 | 0.110 |
Why?
| | Ischemic Attack, Transient | 2 | 2014 | 62 | 0.100 |
Why?
| | Up-Regulation | 1 | 2015 | 872 | 0.100 |
Why?
| | Proportional Hazards Models | 1 | 2015 | 1125 | 0.100 |
Why?
| | Urethra | 1 | 2011 | 58 | 0.100 |
Why?
| | Lymphangioma, Cystic | 1 | 2011 | 4 | 0.100 |
Why?
| | Neoplasms, Multiple Primary | 1 | 2011 | 56 | 0.100 |
Why?
| | Umbilicus | 1 | 2011 | 15 | 0.100 |
Why?
| | Neurologic Examination | 1 | 2011 | 126 | 0.100 |
Why?
| | Brachial Plexus | 1 | 2011 | 29 | 0.100 |
Why?
| | Teratoma | 1 | 2011 | 92 | 0.100 |
Why?
| | Third Ventricle | 2 | 2020 | 14 | 0.100 |
Why?
| | Rhabdoid Tumor | 1 | 2011 | 80 | 0.100 |
Why?
| | Hematoma, Epidural, Cranial | 1 | 2010 | 5 | 0.100 |
Why?
| | Magnetic Resonance Angiography | 2 | 2014 | 210 | 0.100 |
Why?
| | Radiosurgery | 1 | 2014 | 318 | 0.090 |
Why?
| | Practice Patterns, Physicians' | 1 | 2018 | 1200 | 0.090 |
Why?
| | Gene Expression | 1 | 2015 | 1489 | 0.090 |
Why?
| | Reproducibility of Results | 1 | 2017 | 2874 | 0.090 |
Why?
| | Consensus | 2 | 2022 | 534 | 0.090 |
Why?
| | Skull Fracture, Depressed | 1 | 2008 | 1 | 0.090 |
Why?
| | Electronic Health Records | 1 | 2016 | 829 | 0.080 |
Why?
| | Head Injuries, Closed | 1 | 2008 | 55 | 0.080 |
Why?
| | Pia Mater | 1 | 2008 | 4 | 0.080 |
Why?
| | Zygoma | 1 | 2008 | 11 | 0.080 |
Why?
| | Functional Laterality | 1 | 2009 | 208 | 0.080 |
Why?
| | Computer Simulation | 3 | 2021 | 922 | 0.080 |
Why?
| | Topography, Medical | 1 | 2008 | 11 | 0.080 |
Why?
| | Diagnosis, Differential | 2 | 2012 | 1384 | 0.080 |
Why?
| | Temporal Arteries | 1 | 2008 | 47 | 0.080 |
Why?
| | Prenatal Diagnosis | 1 | 2009 | 168 | 0.080 |
Why?
| | Models, Anatomic | 1 | 2008 | 94 | 0.080 |
Why?
| | Foreign Bodies | 1 | 2008 | 98 | 0.080 |
Why?
| | Abnormalities, Multiple | 1 | 2009 | 181 | 0.080 |
Why?
| | Biopsy | 1 | 2011 | 1079 | 0.080 |
Why?
| | Developmental Disabilities | 1 | 2010 | 247 | 0.080 |
Why?
| | Paraganglioma | 1 | 2008 | 48 | 0.080 |
Why?
| | Recurrence | 1 | 2010 | 975 | 0.080 |
Why?
| | Diagnostic Imaging | 1 | 2010 | 294 | 0.080 |
Why?
| | Population Dynamics | 1 | 2008 | 137 | 0.070 |
Why?
| | Signal Transduction | 1 | 2020 | 4709 | 0.070 |
Why?
| | Gestational Age | 1 | 2009 | 765 | 0.070 |
Why?
| | Cerebrovascular Circulation | 1 | 2008 | 204 | 0.070 |
Why?
| | Forecasting | 1 | 2008 | 353 | 0.070 |
Why?
| | Health Services Needs and Demand | 1 | 2008 | 254 | 0.070 |
Why?
| | Cognition Disorders | 1 | 2010 | 529 | 0.070 |
Why?
| | Head and Neck Neoplasms | 1 | 2011 | 471 | 0.070 |
Why?
| | Seizures | 1 | 2008 | 345 | 0.060 |
Why?
| | Computational Biology | 2 | 2020 | 588 | 0.060 |
Why?
| | Cell Survival | 2 | 2019 | 1047 | 0.060 |
Why?
| | Glasgow Coma Scale | 2 | 2018 | 150 | 0.060 |
Why?
| | X-ray Repair Cross Complementing Protein 1 | 1 | 2023 | 16 | 0.060 |
Why?
| | Mutation | 3 | 2023 | 3457 | 0.060 |
Why?
| | Intelligence Tests | 1 | 2023 | 64 | 0.060 |
Why?
| | Stroke | 2 | 2014 | 1047 | 0.060 |
Why?
| | Sex Factors | 1 | 2009 | 1781 | 0.060 |
Why?
| | Cranial Irradiation | 1 | 2023 | 70 | 0.060 |
Why?
| | Chromosomes | 1 | 2023 | 87 | 0.060 |
Why?
| | Patients' Rooms | 1 | 2022 | 13 | 0.060 |
Why?
| | Mass Screening | 1 | 2010 | 1052 | 0.050 |
Why?
| | Abdomen | 1 | 2023 | 110 | 0.050 |
Why?
| | Narcotics | 1 | 2022 | 50 | 0.050 |
Why?
| | Multicenter Studies as Topic | 1 | 2023 | 253 | 0.050 |
Why?
| | Catheters | 1 | 2022 | 61 | 0.050 |
Why?
| | Gene Ontology | 1 | 2021 | 55 | 0.050 |
Why?
| | Epithelial-Mesenchymal Transition | 1 | 2023 | 176 | 0.050 |
Why?
| | Slit Ventricle Syndrome | 1 | 2020 | 1 | 0.050 |
Why?
| | Vancomycin | 1 | 2022 | 79 | 0.050 |
Why?
| | Postoperative Care | 1 | 2022 | 237 | 0.050 |
Why?
| | Transplants | 1 | 2021 | 36 | 0.050 |
Why?
| | Cell Proliferation | 2 | 2019 | 2275 | 0.050 |
Why?
| | DNA Copy Number Variations | 1 | 2021 | 167 | 0.050 |
Why?
| | Transplantation, Heterologous | 1 | 2021 | 194 | 0.050 |
Why?
| | Models, Biological | 1 | 2008 | 1715 | 0.050 |
Why?
| | Survivors | 1 | 2023 | 418 | 0.050 |
Why?
| | Transplantation, Autologous | 1 | 2021 | 191 | 0.050 |
Why?
| | Genes, APC | 1 | 2019 | 13 | 0.040 |
Why?
| | Mice | 3 | 2022 | 15520 | 0.040 |
Why?
| | Athletes | 1 | 2022 | 353 | 0.040 |
Why?
| | Mice, SCID | 1 | 2019 | 333 | 0.040 |
Why?
| | Aminopyridines | 1 | 2019 | 85 | 0.040 |
Why?
| | Critical Care Nursing | 1 | 2019 | 31 | 0.040 |
Why?
| | Surgical Wound | 1 | 2018 | 19 | 0.040 |
Why?
| | Benzamides | 1 | 2019 | 176 | 0.040 |
Why?
| | Asymptomatic Diseases | 1 | 2019 | 81 | 0.040 |
Why?
| | Blood Loss, Surgical | 1 | 2019 | 87 | 0.040 |
Why?
| | Longitudinal Studies | 2 | 2018 | 2513 | 0.040 |
Why?
| | Electronic Mail | 1 | 2018 | 55 | 0.040 |
Why?
| | Germ-Line Mutation | 1 | 2019 | 134 | 0.040 |
Why?
| | Weight Gain | 1 | 2022 | 493 | 0.040 |
Why?
| | Point Mutation | 1 | 2019 | 228 | 0.040 |
Why?
| | Odontogenesis | 1 | 2018 | 10 | 0.040 |
Why?
| | Immunohistochemistry | 2 | 2013 | 1691 | 0.040 |
Why?
| | Standard of Care | 1 | 2018 | 63 | 0.040 |
Why?
| | Laser Capture Microdissection | 1 | 2018 | 26 | 0.040 |
Why?
| | Tissue Culture Techniques | 1 | 2018 | 67 | 0.040 |
Why?
| | Mice, Inbred NOD | 1 | 2019 | 574 | 0.040 |
Why?
| | Tumor Cells, Cultured | 1 | 2019 | 874 | 0.040 |
Why?
| | Drug Approval | 1 | 2018 | 77 | 0.040 |
Why?
| | Overweight | 1 | 2022 | 502 | 0.040 |
Why?
| | Receptors, HIV | 1 | 2017 | 23 | 0.040 |
Why?
| | Mucin-1 | 1 | 2017 | 18 | 0.040 |
Why?
| | Cytogenetic Analysis | 1 | 2017 | 28 | 0.040 |
Why?
| | Indoleamine-Pyrrole 2,3,-Dioxygenase | 1 | 2017 | 44 | 0.040 |
Why?
| | DNA-Binding Proteins | 2 | 2017 | 1346 | 0.040 |
Why?
| | Prevalence | 2 | 2016 | 2326 | 0.040 |
Why?
| | Receptors, Interleukin-6 | 1 | 2017 | 36 | 0.040 |
Why?
| | Canada | 1 | 2018 | 340 | 0.040 |
Why?
| | Fluorescent Antibody Technique | 1 | 2018 | 410 | 0.040 |
Why?
| | Heart-Assist Devices | 1 | 2003 | 485 | 0.040 |
Why?
| | Machine Learning | 1 | 2021 | 331 | 0.040 |
Why?
| | Heart Transplantation | 1 | 2003 | 671 | 0.040 |
Why?
| | Pituitary Gland | 1 | 2018 | 163 | 0.040 |
Why?
| | Intensive Care Units, Pediatric | 1 | 2018 | 157 | 0.040 |
Why?
| | Glial Fibrillary Acidic Protein | 1 | 2017 | 87 | 0.040 |
Why?
| | Xenograft Model Antitumor Assays | 1 | 2019 | 740 | 0.040 |
Why?
| | DNA Methylation | 1 | 2021 | 503 | 0.040 |
Why?
| | Treatment Failure | 1 | 2018 | 341 | 0.040 |
Why?
| | Monitoring, Physiologic | 1 | 2019 | 271 | 0.040 |
Why?
| | Pregnancy | 1 | 2009 | 5690 | 0.040 |
Why?
| | Neuroglia | 1 | 2018 | 157 | 0.040 |
Why?
| | Ki-67 Antigen | 1 | 2017 | 108 | 0.040 |
Why?
| | Interviews as Topic | 1 | 2019 | 599 | 0.040 |
Why?
| | Brain Diseases | 1 | 2018 | 140 | 0.040 |
Why?
| | Health Surveys | 1 | 2018 | 454 | 0.040 |
Why?
| | Transcription Factors | 2 | 2017 | 1570 | 0.040 |
Why?
| | Blotting, Western | 1 | 2019 | 1194 | 0.040 |
Why?
| | Pyrimidines | 1 | 2019 | 382 | 0.040 |
Why?
| | Wounds, Nonpenetrating | 1 | 2019 | 285 | 0.040 |
Why?
| | Microscopy, Confocal | 1 | 2017 | 314 | 0.030 |
Why?
| | Drug Synergism | 1 | 2017 | 339 | 0.030 |
Why?
| | Flow Cytometry | 1 | 2019 | 1085 | 0.030 |
Why?
| | Predictive Value of Tests | 1 | 2020 | 1868 | 0.030 |
Why?
| | Sequence Analysis, RNA | 1 | 2018 | 409 | 0.030 |
Why?
| | Software | 1 | 2020 | 613 | 0.030 |
Why?
| | Sensitivity and Specificity | 1 | 2020 | 1795 | 0.030 |
Why?
| | Image Interpretation, Computer-Assisted | 1 | 2016 | 220 | 0.030 |
Why?
| | Prospective Studies | 2 | 2020 | 6471 | 0.030 |
Why?
| | Lumbar Vertebrae | 1 | 2016 | 215 | 0.030 |
Why?
| | Qualitative Research | 1 | 2019 | 953 | 0.030 |
Why?
| | Quality Improvement | 1 | 2022 | 963 | 0.030 |
Why?
| | Body Mass Index | 1 | 2022 | 2092 | 0.030 |
Why?
| | Animals | 3 | 2022 | 33381 | 0.030 |
Why?
| | Illinois | 1 | 2013 | 38 | 0.030 |
Why?
| | Chicago | 1 | 2013 | 45 | 0.030 |
Why?
| | Registries | 1 | 2020 | 1810 | 0.030 |
Why?
| | Nuclear Proteins | 1 | 2017 | 597 | 0.030 |
Why?
| | Necrosis | 1 | 2013 | 230 | 0.030 |
Why?
| | SMARCB1 Protein | 1 | 2011 | 17 | 0.030 |
Why?
| | Case-Control Studies | 1 | 2019 | 3171 | 0.030 |
Why?
| | History, 19th Century | 1 | 2011 | 61 | 0.030 |
Why?
| | Germany | 1 | 2011 | 89 | 0.030 |
Why?
| | Incidence | 1 | 2018 | 2424 | 0.030 |
Why?
| | Clinical Competence | 1 | 2018 | 951 | 0.030 |
Why?
| | Arthritis, Juvenile | 1 | 2011 | 42 | 0.020 |
Why?
| | Chromosomal Proteins, Non-Histone | 1 | 2011 | 103 | 0.020 |
Why?
| | Phenotype | 1 | 2019 | 3003 | 0.020 |
Why?
| | Practice Guidelines as Topic | 1 | 2018 | 1440 | 0.020 |
Why?
| | Abducens Nerve Diseases | 1 | 2010 | 10 | 0.020 |
Why?
| | History, 20th Century | 1 | 2011 | 281 | 0.020 |
Why?
| | Apoptosis | 1 | 2019 | 2484 | 0.020 |
Why?
| | Brain Ischemia | 1 | 2014 | 310 | 0.020 |
Why?
| | Joint Dislocations | 1 | 2010 | 59 | 0.020 |
Why?
| | Range of Motion, Articular | 1 | 2011 | 369 | 0.020 |
Why?
| | Clothing | 1 | 2008 | 22 | 0.020 |
Why?
| | Obesity | 1 | 2022 | 2746 | 0.020 |
Why?
| | Statistics, Nonparametric | 1 | 2009 | 403 | 0.020 |
Why?
| | Cross-Sectional Studies | 1 | 2018 | 4552 | 0.020 |
Why?
| | Inflammation | 1 | 2018 | 2566 | 0.020 |
Why?
| | Bacterial Infections | 1 | 2009 | 227 | 0.020 |
Why?
| | Polymorphism, Single Nucleotide | 1 | 2013 | 2062 | 0.020 |
Why?
| | New York | 1 | 2003 | 118 | 0.010 |
Why?
| | Shock, Cardiogenic | 1 | 2003 | 53 | 0.010 |
Why?
| | Emergency Treatment | 1 | 2003 | 110 | 0.010 |
Why?
| | Risk Assessment | 1 | 2010 | 3057 | 0.010 |
Why?
| | Stroke Volume | 1 | 2003 | 512 | 0.010 |
Why?
| | Intensive Care Units | 1 | 2003 | 635 | 0.010 |
Why?
| | Hospital Mortality | 1 | 2003 | 814 | 0.010 |
Why?
| | Heart Ventricles | 1 | 2003 | 727 | 0.010 |
Why?
| | Disease Progression | 1 | 2003 | 2490 | 0.010 |
Why?
| | Time Factors | 1 | 2003 | 6412 | 0.010 |
Why?
| | Heart Failure | 1 | 2003 | 1969 | 0.010 |
Why?
|
|
Hankinson's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|